Asac pharma
Asac Pharma is a privately-held Spanish pharmaceutical group headquartered in Alicante that develops, manufactures, and markets prescription medicines (allergy immunotherapy, osteomuscular, dermatology), dermo-cosmetics, food supplements, and CE-marked medical devices across 35+ countries via wholly-owned subsidiaries in Latin America, Morocco, and Spain.
- Company typePrivate
- Founded1995
- HeadquartersAlicante, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Asac pharma does
Asac Pharma (legal entity: Especialidades Farmaceuticas Centrum, S.A.) is a privately-held Spanish pharmaceutical group headquartered in Alicante, Spain, that develops, manufactures, and markets a diversified pharmaceutical and dermo-cosmetic portfolio. Founded in 1995 and employing more than 250 people globally, the group operates through wholly-owned subsidiaries in Spain, Brazil (São Paulo), Mexico (Mexico City, since 1999), Morocco (IBERMA, Had Soualem, since 1993), Colombia (Bogotá, since 2013), Chile (Santiago), and Paraguay (Asunción), reaching patients in 35+ countries via direct sales and commercial distributor partnerships.
The company's product portfolio spans four business lines: prescription medicines organized into osteomuscular (Durfenta, Gotaric, Quinux, Sensedol, Cadelius D, Acenam, Alapanzol), respiratory and allergy immunotherapy (APiORAL sublingual spray, APither SCIT subcutaneous vaccines, APiPRICK skin prick diagnostics, APiMUNE bacterial autovaccines, Armaya Fuerte, Azerix), and dermatology (Flexresan isotretinoin); dermo-cosmetics under the Atache, CPI, and Dermic Plus brands with over 30 years of formulation heritage; the Plesinox 3A food supplement featuring proprietary Polypodium leucotomos extract; and the Hyplus medical device (CE-marked, ISO 13485 certified) for prevention and treatment of grade I–II pressure ulcers. Manufacturing is vertically integrated at EU-GMP certified facilities in Sucina (Murcia), Spain and Had Soualem, Morocco, with biological manufacturing and allergology diagnostic production in São Paulo, Brazil under a long-standing partnership with IPI Brasil.
Asac Pharma monetizes through a B2B pharmaceutical sales model targeting specialist physicians (dermatologists, allergists, rheumatologists) and institutional healthcare channels in its direct markets, complemented by distributor partnerships across the remaining geographies. Revenue is prescription-led for medicines and medical devices, with consumer pull-through in dermo-cosmetics and food supplements. Reported revenue was €47 million in 2022, and the company's leadership (President Eva Martínez, CEO Eliseo Aller) indicates a management-controlled private ownership structure with no disclosed external investors or parent entity.
Asac pharma firmographics
Firmographics- Name
- Asac pharma
- Legal name
- ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A.
- Website
- https://asac.net
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Asac Pharma is a privately-held Spanish pharmaceutical group headquartered in Alicante that develops, manufactures, and markets prescription medicines (allergy immunotherapy, osteomuscular, dermatology), dermo-cosmetics, food supplements, and CE-marked medical devices across 35+ countries via wholly-owned subsidiaries in Latin America, Morocco, and Spain.
- Ownership category
- akta.pro rank
Asac pharma industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cold, Flu & Cough Remedies (HLAIADAB)
- akta.pro secondary industries
- OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where Asac pharma is headquartered
LocationHeadquarters
- HQ city
- Alicante
- HQ country
- Spain
- HQ region
- Europe
Offices9 records
Markets served
Asac pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Prescription Medicines: Pharmaceutical products requiring medical prescription including allergen immunotherapy vaccines, respiratory medicines, and isotretinoin for dermatology
- Cosmetics and Dermocosmetics: Dermo-cosmetic products including Atache (Vitamin C and Retinol formulations), CPI (skin care adjuvants), and Dermic Plus (dermopeeling systems)
- Food Supplements: Plesinox 3A food supplement with Polypodium leucotomos extract, vitamins A, C, and selenium for immune system and skin health
- Medical Devices: CE-certified medical devices including Hyplus for pressure ulcer treatment and prevention
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Asac pharma product offering
Product offeringCore offering
Asac Pharma is a Spanish pharmaceutical group that develops, manufactures, and markets prescription medicines, dermo-cosmetics, food supplements, and medical devices. Its portfolio spans four therapeutic lines: osteomuscular (pain management), respiratory (allergen immunotherapy and bacterial autovaccines), dermatology (isotretinoin), and adjunctive product categories. Products are sold through wholly-owned subsidiaries and distributor networks across 35+ countries.
Product overview
Asac Pharma is a pharmaceutical company offering a diversified portfolio organized across four main business lines: Medicines (prescription and over-the-counter products), Cosmetics (dermocosmetics), Food Supplements, and Medical Devices. The Medicines division includes three therapeutic lines: Osteomuscular (pain management products including Durfenta, Gotaric, Quinux, Sensedol, Cadelius D, Acenam, Alapanzol), Respiratory (allergy immunotherapy products including APiORAL, APither SCIT, APiPRICK, APiMUNE, Armaya Fuerte, Azerix), and Dermatology (Flexresan isotretinoin). The Cosmetics line features Atache (Vitamin C and Retinol formulations), CPI (skin condition adjuvants), and Dermic Plus (derma-peeling systems). The Food Supplements line includes Plesinox 3A. The Medical Devices line features Hyplus for pressure ulcer treatment. The company operates production facilities in Spain (Alicante and Sucina, Murcia) and has subsidiaries in Brazil, Mexico, Morocco, Colombia, Chile, and Paraguay.
Differentiator
Problem solved
Functional benefit
Brands
- ATACHE: Dermo-cosmetic products for skin care and aesthetic treatments. Pioneer in Spain in pure and stable mixtures of Vitamin C and Retinol with over 30 years of experience.
- CPI
- Dermic Plus
- Hyplus
- Plesinox 3A
- APiORAL
- Apither SCIT
- Apimune
- Armaya Fuerte
Products and services
- APiORAL
Quantifiable outcome
- Allergy immunotherapy effectiveness observable within months of treatment initiation
- +1 more outcomes
Companies that use Asac pharma
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Asac pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Asac pharma partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- IPI Brasil (Instituto de Pesquisa Importacao)coreStrategic partnership with IPI Brasil for biological medicines manufacturing and allergology diagnostics in Brazil. The facility produces skin test diagnostics and individualized immunological vaccines. Located in Sao Paulo with over 20 years of partnership history.
- IBERMA (Iberma SARL)coreMoroccan subsidiary established in Had Soualem (30km from Casablanca) with EU-GMP certified manufacturing facility. Over 180 employees producing 50+ pharmaceutical products. Certified by Spanish authorities. Enables African market access for Asacpharma group.
- Dermatology Healthcare ProfessionalscoreAtache dermo-cosmetic brand partners with dermatologists for product recommendations and professional skin care treatments. Over 30 years of formulation expertise in Vitamin C and Retinol products.
- Medical Associations and InstitutionsminorPartnerships with medical associations including SEPAR (Sociedad Española de Neumología), AEDV (Academia Española de Dermatología), SER (Sociedad Española de Reumatología), and international respiratory/immunology societies for professional education and research collaboration.
Scale indicators7 records
Recent moves12 records
Expansion highlights6 records
Asac pharma competitors and assessment
Company assessmentDirect peers
- Leti Pharma: European pharmaceutical group specializing in allergen immunotherapy, dermatology, and vaccines with similar niche positioning. Leti competes directly with Asac in allergen extracts, individualized vaccines, and dermo-cosmetic adjuvants across Europe and LATAM.
- Stallergenes Greer: Global leader in allergen immunotherapy (sublingual and subcutaneous) with a comparable product profile to APiORAL and APither SCIT. Stallergenes Greer competes for the same specialist allergist customer base and addresses the same respiratory allergy indications.
- ALK-Abelló: Danish specialty pharma focused on allergy immunotherapy, diagnostics, and respiratory care. ALK offers sublingual tablets and subcutaneous vaccines that directly overlap with Asac's APiORAL and APither franchises in respiratory allergy.
- Allergy Therapeutics: UK-based specialty pharmaceutical company developing and commercializing allergy immunotherapy vaccines and diagnostics. Allergy Therapeutics is a comparable mid-cap player in the same allergen immunotherapy category.
- HAL Allergy: European specialist in allergen immunotherapy and diagnostics with sublingual and subcutaneous products. HAL Allergy competes with Asac in standardized and individualized vaccine formats across European and select international markets.
Broad incumbents
- Dermapharm Holding: German pharmaceutical company with a strong dermatology, allergy, and consumer health portfolio including dermo-cosmetics. Dermapharm operates on a larger scale but overlaps with Asac's dermatology and consumer health lines.
- Pierre Fabre Group: French dermo-cosmetic and pharmaceutical group with leading positions in dermatology (Ducray, Avène, A-Derma). Pierre Fabre competes broadly with Asac's Atache and CPI dermo-cosmetic brands in dermatology channels.
- Galderma: Global dermatology-focused company with prescription, aesthetic, and consumer skin-care brands. Galderma is a larger incumbent overlapping with Asac's dermatology prescription (isotretinoin) and dermo-cosmetic portfolio.
Emerging players
- Inmunotek: Spanish-origin allergen immunotherapy and respiratory pharmaceutical group with overlapping SLIT/SCIT offerings. Inmunotek is an emerging peer with comparable product categories and geographic footprint in Spanish-speaking markets.
Regional players
- Bial Industrial Farmacéutica: Portuguese pharmaceutical company with respiratory, allergy, and consumer health products serving Iberian and LATAM markets. Bial is a regional peer with overlapping respiratory prescription and OTC offerings relevant to Asac's Spain-anchored distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Asac pharma social profiles
Digital presenceAsac pharma compliance and trust
Trust signalCompliance3 records
Asac pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Asac pharma leadership team
Management profileNumber of profiles
Profiles13 records
Asac pharma subsidiaries and ownership
Company hierarchySubsidiaries6 records
Asac pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Asac pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Asac pharma
What does Asac pharma do?
Asac Pharma is a Spanish pharmaceutical group that develops, manufactures, and markets prescription medicines, dermo-cosmetics, food supplements, and medical devices. Its portfolio spans four therapeutic lines: osteomuscular (pain management), respiratory (allergen immunotherapy and bacterial autovaccines), dermatology (isotretinoin), and adjunctive product categories. Products are sold through wholly-owned subsidiaries and distributor networks across 35+ countries.
Is Asac pharma a public or private company?
Asac pharma is a private company. It is classified as management employee owned and is currently operating.
When was Asac pharma founded?
Asac pharma was founded in 1995. It employs 11 to 50 people.
Where is Asac pharma based?
Asac pharma is headquartered in Alicante, Spain, in the Europe region.
How does Asac pharma make money?
Four revenue lines are on record. Prescription Medicines are the primary driver. The others are cosmetics and Dermocosmetics, food Supplements and medical Devices.
Who are Asac pharma's main competitors?
Direct peers on record are Leti Pharma, Stallergenes Greer, ALK-Abelló, Allergy Therapeutics and HAL Allergy. Broad incumbents are Dermapharm Holding, Pierre Fabre Group and Galderma. Inmunotek is listed as an emerging player. Bial Industrial Farmacéutica is listed as a regional player.
Does Asac pharma have an API?
No public API is recorded for Asac pharma.
What industry is Asac pharma in?
Asac pharma's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIADAB, Cold, Flu & Cough Remedies, with a secondary code of CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief). Its NAICS code is 325412 and its SIC code is 2834.